N-Ethyl-2,3-dioxopiperazine: A Key Pharmaceutical Intermediate for Cefoperazone Synthesis
Unlock advanced antibiotic production with our high-purity N-Ethyl-2,3-dioxopiperazine.
Get a Quote & SampleProduct Core Value
N-Ethyl-2,3-dioxopiperazine
This essential pharmaceutical intermediate is critical for the synthesis of Cefoperazone, a vital third-generation cephalosporin antibiotic. Valued for its stability and consistent quality, it plays a pivotal role in manufacturing life-saving medications and supports ongoing drug development efforts.
- The reliable supply of N-Ethyl-2,3-dioxopiperazine intermediate for Cefoperazone synthesis is crucial for consistent antibiotic production.
- Our CAS 59702-31-7 pharmaceutical intermediate ensures high purity for advanced drug synthesis.
- This white powder chemical intermediate is ideal for antibiotic production, meeting stringent industry requirements.
- Leverage the versatility of this piperazine derivative for robust drug development pipelines.
Advantages Delivered
High Purity & Quality
With purity levels of u226598% and impurities u22640.1%, our N-Ethyl-2,3-dioxopiperazine guarantees exceptional quality for your sensitive pharmaceutical processes.
Critical for Antibiotic Production
As a key component in Cefoperazone synthesis, this chemical intermediate directly contributes to the production of effective antibiotics.
Stable and Reliable
Its defined physical and chemical properties, including a melting point of 106-110u00b0C, ensure stability during manufacturing, making it a dependable choice for chemical synthesis.
Key Applications
Pharmaceutical Synthesis
Essential for the production of Cefoperazone, contributing to the availability of critical antibiotics.
Drug Intermediate
Serves as a vital building block in the complex synthesis pathways of various pharmaceutical compounds.
Research & Development
The versatile piperazine structure offers potential for developing novel therapeutic agents.
API Manufacturing
High purity and consistent quality make it suitable for Active Pharmaceutical Ingredient (API) manufacturing.